| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4268917 | European Urology Focus | 2016 | 6 Pages |
Abstract
Comprehensive genomic profiling in the course of clinical care in the community oncology setting can delineate subgroups of patients with advanced kidney cancer who stand to benefit more from specific molecular-targeted agents.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Thai H. Ho, Toni K. Choueiri, Kai Wang, Jose A. Karam, Zachary Chalmers, Garrett Frampton, Julia A. Elvin, Adrienne Johnson, Xueli Liu, Yulan Lin, Richard W. Joseph, Melissa L. Stanton, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross,